Catapano, A., Pirillo, A., & Norata, G. (2017). Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives.
Chicago Style (17th ed.) CitationCatapano, A., A. Pirillo, and Giuseppe Norata. Anti-PCSK9 Antibodies for the Treatment of Heterozygous Familial Hypercholesterolemia: Patient Selection and Perspectives. 2017.
MLA (9th ed.) CitationCatapano, A., et al. Anti-PCSK9 Antibodies for the Treatment of Heterozygous Familial Hypercholesterolemia: Patient Selection and Perspectives. 2017.
Warning: These citations may not always be 100% accurate.